Efficacy and safety of antifungal prophylaxis in surgical intensive care unit patients: A systematic review and meta- analysis of randomized controlled trials

Kadariswantiningsih, Ika N. and Empitu, Maulana A. and Danardono, Edwin and Rahmatullah, Ivan and Widya, Alicia Margaretta and Koendhori, Eko Budi and Rampengan, Derren D.C.H. and Arima, Ekram and Endraswari, Pepy D.W.I. (2026) Efficacy and safety of antifungal prophylaxis in surgical intensive care unit patients: A systematic review and meta- analysis of randomized controlled trials. Biomedical Reports, 24 (5).

[img] Text
Efficacy and safety of antifungal prophylaxis.pdf
Restricted to Registered users only

Download (5MB) | Request a copy
Official URL: https://www.scopus.com/pages/publications/10503441...

Abstract

Invasive fungal infections (IFIs) are serious complications among surgical intensive care unit (ICU) patients, leading to substantial morbidity and mortality. Antifungal prophylaxis and preemptive strategies are employed to reduce the risk of such infections, although their effectiveness and safety remain subjects of debate. The present systematic review and meta-analysis included randomized controlled trials evaluating antifungal prophylaxis or pre-emptive therapy in surgical ICU patients. Searches in the PubMed, Scopus, Google Scholar and Science Direct databases up to February 2025 identified 11 eligible studies. Pooled analyses demonstrated that antifungal prophylaxis significantly reduced the risk of IFIs risk ratio (RR)=0.63; 95% CI, 0.50 0.78; P<0.0001. While azoles were effective, polyenes and echinocandins did not show a significant effect. No significant effect on overall mortality was observed (RR=0.99; 95% CI, 0.75 1.31; P=0.9186), and there was no increased risk of severe adverse events (RR=0.98; 95% CI, 0.70 1.36) or liver dysfunction (RR=0.91; 95% CI, 0.31.65). The analysis did not reveal strong evidence of publication bias as evaluated by funnel plots. Overall, the results indicated that antifungal prophy laxis appeared to be effective in reducing the risk of IFIs in surgical ICU patients without elevating the risk of serious side effects. The implementation of this therapy should be targeted toward high risk populations, considering the antifungal type, local resource availability and antimicrobial management parameters. The evidence of prophylaxis therapy in low risk population is limited, since the majority of included studies in the present meta Nanalysis analyzed high risk populations. Copyright © 2026 Kadariswantiningsih et al.

Item Type: Article
Additional Information: Cited by: 0; All Open Access; Gold Open Access; Green Open Access
Uncontrolled Keywords: antifungal prophylaxis, pre‑emptive, surgical intensive care unit, fungal infections
Subjects: R Medicine > RD Surgery
R Medicine > RD Surgery > RD520-599.5 Surgery by region, system, or organ
Divisions: Artikel Ilmiah > SCOPUS INDEXED JOURNAL
Creators:
CreatorsNIM
Kadariswantiningsih, Ika N.UNSPECIFIED
Empitu, Maulana A.UNSPECIFIED
Danardono, EdwinUNSPECIFIED
Rahmatullah, IvanUNSPECIFIED
Widya, Alicia MargarettaUNSPECIFIED
Koendhori, Eko BudiUNSPECIFIED
Rampengan, Derren D.C.H.UNSPECIFIED
Arima, EkramUNSPECIFIED
Endraswari, Pepy D.W.I.UNSPECIFIED
Depositing User: Dewi Puspita
Date Deposited: 26 Aug 2026 02:28
Last Modified: 26 Aug 2026 02:28
URI: http://repository.unair.ac.id/id/eprint/142953
Sosial Share:

Actions (login required)

View Item View Item